Trade Summary

5 days ago, Jenne Kyle, serving as EVP, Chf GL Pdt Str Ofcr at Ionis Pharmaceuticals Inc (IONS), sold 4,902 shares at $75.17 per share, for a total transaction value of $368,488.00. Following this transaction, Jenne Kyle now holds 23,713 shares of IONS.

This sale represents a 17.00% decrease in Jenne Kyle's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, April 16, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 17, 2026, 1 day after the trade was made.

Ionis Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.